Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Kaitlin Mayne

Dr Kaitlin Mayne

Kaitlin Mayne

Clinical Research Fellow

Kaitlin is working on the EMPA-KIDNEY trial of empagliflozin in patients with chronic kidney disease while working towards a higher degree during her time at the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU).

She moved to Oxford in August 2021 to join the Heart and Renal Studies Group at CTSU as a Clinical Research Fellow on an “out-of-programme research” basis. 

Kaitlin studied medicine at the University of Dundee, qualifying in 2016 before commencing foundation training in Glasgow. She continued clinical training in Glasgow, completing two years of core medical training before beginning higher specialty training in Renal & General Internal Medicine in 2020. 

Recent publications

More publications